Alzheimer - passive immunotherapy moderate Alzheimer disease

ctSearch Results

Original Query

Alzheimer - passive immunotherapy moderate Alzheimer disease

Search Results

1. alzheimer passive immunotherapy moderate alzheimer

Preview

• Elan announced that a phase 1 clinical study of passive immunotherapy with humanized monoclonal anti-amyloid beta peptide antibody in patients with mild to moderate Alzheimer`s disease had been started at the end of 2003


• The experimental vaccine, AN-1792, which had shown early promise as an effective immunotherapy against mild to moderate Alzheimer disease, will no longer be pursued in clinical trials for treatment of mild to moderate Alzheimer disease

---

For more information on each topic click the link(s) above.

---

Contact

Web : http://c-t-search.info
E-mail : E-Mail
Search Engine : c-t-search.appspot.com
ctMedBrowser : More ctMedBrowser Info
Sponsor : Peta Software Promo

[Return to Medical Expert][Return to Alzheimer Expert]